rs786205846
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000217381.3(SNTA1):c.40G>A(p.Glu14Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000121 in 1,282,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E14E) has been classified as Likely benign.
Frequency
Consequence
ENST00000217381.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNTA1 | NM_003098.3 | c.40G>A | p.Glu14Lys | missense_variant | 1/8 | ENST00000217381.3 | NP_003089.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNTA1 | ENST00000217381.3 | c.40G>A | p.Glu14Lys | missense_variant | 1/8 | 1 | NM_003098.3 | ENSP00000217381 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000133 AC: 20AN: 150834Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000198 AC: 8AN: 40454Hom.: 0 AF XY: 0.000203 AC XY: 5AN XY: 24646
GnomAD4 exome AF: 0.000119 AC: 135AN: 1131130Hom.: 0 Cov.: 31 AF XY: 0.000129 AC XY: 71AN XY: 551194
GnomAD4 genome AF: 0.000133 AC: 20AN: 150942Hom.: 0 Cov.: 31 AF XY: 0.000136 AC XY: 10AN XY: 73740
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 04, 2021 | - - |
Long QT syndrome 12 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 15, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 19, 2018 | The Glu14Lys variant in the SNTA1 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Glu14Lys results in a non-conservative amino acid substitution of a negatively charged Glutamic acid residue with a positively charged Histidine residue at a position that is conserved across species. However, no mutations have been reported in association with LQTS in nearby residues indicating this region of the protein may be tolerant of change. With the clinical and molecular information available at this time, we cannot definitively determine if Glu14Lys is a disease-causing mutation or a rare benign variant. - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | This variant has not been reported in the literature in individuals affected with SNTA1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 190932). This variant is present in population databases (rs786205846, gnomAD 0.05%). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 14 of the SNTA1 protein (p.Glu14Lys). - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 24, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at